SK Bioscience Co Ltd Strategic Asset Allocation Index
SK Bioscience Co Ltd strategic asset allocation index. SK Bioscience Co Ltd (302440) has a Strategic Asset Allocation Index of 16.7% as of September 2022. Strategic assets (PP&E of ₩285.90 Billion plus long-term investments of ₩-) total ₩285.90 Billion, measured against net assets of ₩1.71 Trillion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check SK Bioscience Co Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of SK Bioscience Co Ltd (2020–2021)
Strategic asset allocation index of SK Bioscience Co Ltd from 2020 to 2021. This chart shows how SK Bioscience Co Ltd's Strategic Asset Allocation Index has evolved across 2 annual periods from 2020 to 2021. As of September 2022, the index stands at 16.7%, representing strategic assets of ₩285.90 Billion against net assets of ₩1.71 Trillion KRW.
SK Bioscience Co Ltd Strategic Asset Allocation Index by Year (2020–2021)
SK Bioscience Co Ltd strategic asset allocation index by year from 2020 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for SK Bioscience Co Ltd from 2020 to 2021, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see SK Bioscience Co Ltd (302440) market capitalisation.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 13.8% | ₩220.98 Billion | ₩220.98 Billion | ₩- | ₩1.60 Trillion | ▼ -58.0 pp |
| 2020 | 71.8% | ₩189.48 Billion | ₩189.48 Billion | ₩- | ₩263.79 Billion | — |